Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Neoplasm”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01865617
What this trial is testing

Laboratory Treated T Cells in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma, or Acute Lymphoblastic Leukemia

Who this might be right for
CD19-Positive Neoplastic Cells PresentRecurrent Adult Acute Lymphoblastic LeukemiaRecurrent Chronic Lymphocytic Leukemia+10 more
Fred Hutchinson Cancer Center 204
Not applicableAvailableNCT06872489
What this trial is testing

Expanded Access Protocol for the Use of SL-28 in the Treatment of Advanced Solid Tumors

Who this might be right for
Neuroblastoma in ChildrenNeuroblastoma, Recurrent, RefractoryAdvanced Cancer+7 more
Second Life Therapeutics
Early research (Phase 1)Study completedNCT01933568
What this trial is testing

Combined CFRT and SABR in Stage II and III NSCLC With Peripheral Tumors Smaller Than 5 cm.

Who this might be right for
Inoperable Locally Advanced Non Small Cell Lung Cancer
The Netherlands Cancer Institute 15
Early research (Phase 1)Study completedNCT00030368
What this trial is testing

Bortezomib and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
National Cancer Institute (NCI) 45
Testing effectiveness (Phase 2)WithdrawnNCT06090318
What this trial is testing

Milademetan in Combination With Atezolizumab in Patients With Advanced Solid Tumors With CDKN2A Loss

Who this might be right for
Advanced Solid TumorCDKN2ANSCLC+7 more
Rain Oncology Inc
Not applicableEnded earlyNCT00513318
What this trial is testing

Pilot Study of Reduced-Intensity Umbilical Cord Blood Transplantation in Adult Patients Wtih Advanced Hematopoietic Malignancies

Who this might be right for
Acute Myeloid LeukemiaMyelodysplasiaAcute Lymphoblastic Leukemia+4 more
University of California, San Francisco 15
Early research (Phase 1)Study completedNCT05065710
What this trial is testing

ZL-1211 in Patients With Advanced Solid Tumor

Who this might be right for
Advanced Solid Tumor
Zai Biopharmaceutical (Suzhou) Co., Ltd. 34
Early research (Phase 1)Study completedNCT00004913
What this trial is testing

Combination Chemotherapy in Treating Patients With Advanced Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
Northwestern University
Not applicableEnrolling By InvitationNCT07346248
What this trial is testing

Postoperative Complications After Neoadjuvant Chemoradiotherapy or Short-course Radiotherapy and Total Neoadjuvant Treatment: a Multicentric Retrospective Cohort Study

Who this might be right for
Adult Patients With Locally Advanced Rectal Cancer Indicated to Neoadjuvant Therapy and Surgery
Istituto Clinico Humanitas 266
Early research (Phase 1)Ended earlyNCT03871348
What this trial is testing

A First-in-Human Dose Escalation and Expansion Study to Evaluate Intratumoral Administration of SAR441000 as Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors

Who this might be right for
Metastatic Neoplasm
Sanofi 77
Post-approval studies (Phase 4)Study completedNCT01196078
What this trial is testing

Tarceva (Erlotinib) in Elderly Patients With Advanced Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Hoffmann-La Roche 114
Testing effectiveness (Phase 2)Looking for participantsNCT05636215
What this trial is testing

A First-in-human Study of IBI354 in Subjects with Locally Advanced Unresectable or Metastatic Solid Tumors

Who this might be right for
Locally Advanced Unresectable or Metastatic Solid Tumors
Innovent Biologics (Suzhou) Co. Ltd. 368
Early research (Phase 1)Study completedNCT00499135
What this trial is testing

Sunitinib Malate in Treating Patients With Unresectable or Metastatic Kidney Cancer or Other Advanced Solid Tumors

Who this might be right for
Adult Solid NeoplasmClear Cell Renal Cell CarcinomaRecurrent Renal Cell Carcinoma+2 more
National Cancer Institute (NCI) 25
Large-scale testing (Phase 3)Study completedNCT00931008
What this trial is testing

Study to Evaluate SID 530 Compared to Taxotere

Who this might be right for
Non-Small Cell Lung Cancer
SK Chemicals Co., Ltd. 42
Testing effectiveness (Phase 2)Looking for participantsNCT06667908
What this trial is testing

JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Johnson & Johnson Enterprise Innovation Inc. 130
Early research (Phase 1)Study completedNCT02215850
What this trial is testing

Safety Study of SLC-0111 in Subjects With Advanced Solid Tumours

Who this might be right for
Solid Tumours
Welichem Biotech Inc. 24
Early research (Phase 1)Study completedNCT00003890
What this trial is testing

MG98 in Treating Patients With Advanced Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
NCIC Clinical Trials Group 19
Early research (Phase 1)Study completedNCT02728349
What this trial is testing

Tolerance and Pharmacokinetic Study of Chlorogenic Acid to Advanced Glioblastoma

Who this might be right for
Glioblastoma
Sichuan J.Z. Bio-chemical Science and Technology Development Co., Ltd 26
Testing effectiveness (Phase 2)Looking for participantsNCT06903858
What this trial is testing

Toripalimab Plus Celecoxib for dMMR/MSI-H Locally Advanced Colorectal Cancer

Who this might be right for
Colorectal CancerMicrosatellite Instability HighMismatch Repair Deficiency
Sun Yat-sen University 105
Early research (Phase 1)Ended earlyNCT00932126
What this trial is testing

This Is The First Study Using Escalating Doses Of PF-03758309, An Oral Compound, In Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Pfizer 35
Next Page